Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Tobias R. Chapman, George E. Laramore, Peter F. Orio
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
1993
Current thyroid cancer trends in the united states
10.1001/jamaoto.2014.1 · 2014
Cancer statistics
2015
Unresolved referenced work
2015
Cancer statistics, 2009
2009
Long-term risks for thyroid cancer and other neoplasms after exposure to radiation
10.1038/ncpendmet0022 · 2005
Unresolved referenced work
2010
The role of external beam radiation and targeted therapy in thyroid cancer
10.1016/j.semradonc.2012.03.010 · 2012
Thyroid carcinoma
10.1016/s0140-6736(03)12488-9 · 2003
Revised American Thyroid Association Management guidelines for patients with thyroid nodules and differentiated thyroid cancer
10.1089/thy.2009.0110 · 2009
Revised American Thyroid Association Guidelines for the management of medullary thyroid carcinoma
10.1089/thy.2014.0335 · 2015
American Thyroid Association Guidelines for management of patients with anaplastic thyroid cancer
10.1089/thy.2012.0302 · 2012
Cd133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy
10.1007/s00259-012-2242-5 · 2013
Patterns of relapse following radiotherapy for differentiated thyroid cancer: Implication for target volume delineation
10.1016/j.radonc.2008.05.023 · 2008
Results of postoperative radiation therapy in medullary carcinoma of the thyroid: A retrospective study by the french federation of cancer institutes–the radiotherapy cooperative group
10.1016/0167-8140(92)90298-9 · 1992
Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: Analysis of the surveillance, epidemiology, and end results 1983-2002
10.1097/coc.0b013e31816a61f3 · 2008
Anaplastic thyroid carcinoma: Pathogenesis and emerging therapies
10.1016/j.clon.2010.03.013 · 2010
Fast neutron radiotherapy: Where have we been and where are we going? The jury is still out–regarding Maor et al., IJROBP 1995;32:599-604
10.1016/0360-3016(95)00185-2 · 1995
Biological factors influencing the rbe of neutrons: Implications for their past, present and future use in radiotherapy
10.1667/0033-7587(2001)156[0125:bfitro]2.0.co;2 · 2001
Neutron radiotherapy for recurrent pleomorphic adenomas of major salivary glands
10.1002/hed.10027 · 2001
Treatment of locally advanced adenoid cystic carcinoma of the head and neck with neutron radiotherapy
10.1016/s0360-3016(99)00445-9 · 2000
Neutron radiotherapy for adenoid cystic carcinoma of minor salivary glands
10.1016/s0360-3016(96)00213-1 · 1996
Neutron radiotherapy for the treatment of locally advanced major salivary gland tumors
10.1002/(sici)1097-0347(199905)21:3<255::aid-hed11>3.0.co;2-2 · 1999
Neutron radiotherapy for adenoid cystic carcinoma of the lacrimal gland
10.1097/iop.0b013e318295f99b · 2013
Neutron vs photon irradiation of inoperable salivary gland tumors: Results of an RTOG-MRC cooperative randomized study
10.1016/0360-3016(88)90188-5 · 1988
Fast neutron radiotherapy for sarcomas of soft tissue, bone, and cartilage
10.1097/00000421-198908000-00009 · 1989
Neutron versus photon irradiation for unresectable salivary gland tumors: Final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council
10.1016/0360-3016(93)90233-l · 1993
Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy
10.1002/hed.21257 · 2010
Observations on pulmonary metastases in patients after single doses and multiple fractions of fast neutrons and cobalt-60 gamma rays
10.1016/0014-2964(81)90056-6 · 1981
High energy (42-66 mev reactions) fast neutron dose optimization studies in the head and neck, thorax, upper abdomen, pelvis and extremities
10.1016/0167-8140(90)90030-z · 1990
Fast-neutron therapy in advanced head and neck cancer: A collaborative international randomized trial
10.1016/0360-3016(94)00595-c · 1995
Unilateral total lobectomy: Is it sufficient surgical treatment for patients with ames low-risk papillary thyroid carcinoma?
10.1016/s0039-6060(98)70035-2 · 1998
Low-risk differentiated thyroid cancer: The need for selective treatment
10.1007/bf02303583 · 1997
Extent of surgery affects survival for papillary thyroid cancer
10.1097/sla.0b013e31814697d9 · 2007
Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years
10.1111/j.1365-2265.2005.02358.x · 2005
Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pt4)
10.1002/(sici)1097-0142(19960101)77:1<172::aid-cncr28>3.0.co;2-1 · 1996
Papillary thyroid carcinoma: Prognostic factors and the role of radioiodine and external radiotherapy
10.1016/s0360-3016(01)02686-4 · 2002
Papillary and follicular thyroid cancer: Impact of treatment in 1578 patients
10.1016/0360-3016(88)90381-1 · 1988
Adjuvant external beam radiation for medullary thyroid carcinoma
10.1002/jso.21557 · 2010
Medullary thyroid cancer: Analyses of survival and prognostic factors and the role of radiation therapy in local control
10.1089/thy.1996.6.305 · 1996
Braf inhibition in brafv600e-positive anaplastic thyroid carcinoma
10.6004/jnccn.2016.0030 · doi-reference
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: Results from a phase II study
10.1200/jco.2007.15.9566 · doi-reference
A phase II study of imatinib in patients with advanced anaplastic thyroid cancer
10.1089/thy.2010.0057 · doi-reference
Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid
10.1089/thy.2012.0103 · doi-reference
Multicenter study differentiated thyroid carcinoma (msds). Diminished acceptance of adjuvant external beam radiotherapy
10.1055/s-0038-1625735 · doi-reference
Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy
10.1016/j.ijrobp.2004.05.032 · doi-reference
Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens
10.1002/cncr.22203 · doi-reference
Postoperative radiotherapy for advanced medullary thyroid cancer–local disease control in the modern era
10.1002/hed.20791 · doi-reference
A role for radiotherapy in the management of advanced medullary thyroid carcinoma: The Mayo Clinic experience
10.4081/rt.2013.e37 · doi-reference